The FDA today warned consumers and health care providers not to use an unapproved product called “bismacine” New Lyme Disease Treatment Drug also known as chromacine that’s sometimes used to treat.The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine Lyme Disease Treatment Drug.
Bismacine is an injectable product that has been used to treat Lyme disease, which is a tick-borne bacterial infection. But bismacine is not approved for anything, including Lyme disease. Bismacine New Lyme Disease Treatment Drug is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of “alternative health” or by people claiming to be medical doctors, according to the FDA.Bismacine New Lyme Disease Treatment Drug contains high amounts of bismuth, a heavy metal that is used in some medications taken by mouth to treat Helicobacter pylori, bacteria that can cause stomach.